T 0620/08 (Oxo-pyridine/ENCYSIVE) vom 04.05.2011
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2011:T062008.20110504
- Datum der Entscheidung
- 4. Mai 2011
- Aktenzeichen
- T 0620/08
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 00930450.2
- IPC-Klasse
- C07D 405/12
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden verteilt (C)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Propanoic acid derivatives that inhibit the binding of integrins to their receptors
- Name des Antragstellers
- ENCYSIVE PHARMACEUTICALS, INC.
- Name des Einsprechenden
- Vertex Pharmaceuticals Incorporated
- Kammer
- 3.3.01
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84
- Schlagwörter
- Admissibility of documents late-filed during opposition proceedings: (yes) partly
Late-filed ground for opposition - considered
Main, first and second auxiliary request: novelty (no) special - meaning of terms used in patent specification considered
Adjournment of oral proceedings (no) - no new issues
Fourth auxiliary request: novelty (yes); inventive step (yes) - oxo-pyridine compounds non-obvious alternative - Orientierungssatz
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the fourth auxiliary request filed during the oral proceedings on 4 May 2011:
- Description: - page 8 as filed during the oral
proceedings on 4 May 2011
- pages 3-7 and 9-25 of the patent
specification.
- Claims: Claim 1-9 as filed during the oral
proceedings on 4 May 2011